New Products?

Quote






Nope. Only thing on horizon here is the imminent dismantling and sell off of Bausch and Lomb - all divisions. Board has been quiet becuase workforce is waiting on their pink slips.
 


















Anonymous said:
Why yes, there is this new version of ReNu coming out with Alexidine....supposedly a blockbuster.
Click to expand...

Is this a copy cat to AMO's Revitalens that has alexidine? Why did B+L get rid of alexidine in the first place when MoistureLoc had alexidine and at least from a clinical point of view was an extremely successful product? Seems silly that AMO is benefiting from B+L technology that B+L invented first and then abandoned due to very poor management decisions.

The new B+L CEO probably does not know any better and thinks that the management has come up with a brand new technology where in reality it is the same technology B+L had 6 years ago but abandoned because of poor advice from the R+D management.
 






Anonymous said:
Is this a copy cat to AMO's Revitalens that has alexidine? Why did B+L get rid of alexidine in the first place when MoistureLoc had alexidine and at least from a clinical point of view was an extremely successful product? Seems silly that AMO is benefiting from B+L technology that B+L invented first and then abandoned due to very poor management decisions.

The new B+L CEO probably does not know any better and thinks that the management has come up with a brand new technology where in reality it is the same technology B+L had 6 years ago but abandoned because of poor advice from the R+D management.
Click to expand...

The lack of evidence based decisions by D&R decision makers cause this to happen. Only one or two people make all decisions in this organization and the decisions are based on what benefits their careers not on what is good for the company. Since the CEO changes every year or two these BS 'ers can BS one CEO after another that they are making decisions that help the company. If the CEO does not have a technical background they are really easy to baffle with scientific mumbo jumbo that sounds good to the technological novice but has an agenda that has nothing to do with company profits.
 


































































Top Bottom
Back
Quote